H&K names Oestreicher to head U.S. pharma practice

Hill & Knowlton has named DeVries' Paul Oestreicher to head
its U.S. health and pharmaceutical practice.
Oestreicher, most recently head of the healthcare practice at DeVries,
previously led North American communications for Sanofi-Synthelabo and has served in various communications roles at Hoffmann-LaRoche, Wyeth and Edelman Public Relations.
He reports to U.S. chairman MaryLee Sachs.
Paul McDade, who previously headed Hill & Knowlton's worldwide healthcare practice, left the firm in March to work on a documentary film.


 

You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.